-
From nanoparticles to biocides: how toxic chemicals alter lipid homeostasis and accelerate atherosclerotic events
Ok-Nam Bae Hanyang University, Republic of Korea 13:00~13:20 -
Immune modulation of lipid metabolism promotes BAT whitening under thermoneutral conditions
Jun Young Hong Yonsei University, Republic of Korea 13:20~13:40 -
Role of MCU in human platelet aggregation
Jin O-Uchi University of South Florida, USA 13:40~14:00 - Panel Discussion 14:00~14:30
-
Deep dive into PCSK9: the master regulator of LDL metabolism and inflammation
Hyun-Duk Jang Seoul National University, Republic of Korea 14:40~15:00 -
siRNA-based lipid therapies: a revolution in cholesterol management
Jin Wi Gachon University, Republic of Korea 15:00~15:20 -
Novel strategies for familial hypercholesterolemia management beyond statins
Rodrigo Alonso Center for Advanced Metabolic Medicine and Nutrition, Chile 15:20~15:40 - Panel Discussion 15:40~16:10
-
Mechanisms linking socioeconomic status and cardiovascular risk
Sung Hee Choi Seoul National University, Republic of Korea 16:20~16:40 -
Epidemiologic evidence on socioeconomic status and cardiovascular outcomes
Jong-Ha Baek Gyeongsang National University, Republic of Korea 16:40~17:00 -
New models for CVD risk assessment: incorporating socioeconomic data
Sadiya S. Khan Northwestern University, USA 17:00~17:20 - Panel Discussion 17:20~17:50
-
2024 KSoLA consensus on secondary dyslipidemia
Jae Hyun Bae Seoul National University, Republic of Korea 08:30~08:50 -
Understanding the progression of obesity-induced organ damage: Insights from the EAS staging system
Dae Young Cheon Hallym University, Republic of Korea 08:50~09:10 -
Sex-specific gaps in lipid management and ASCVD
Hyun-Jin Kim Hanyang University, Republic of Korea 09:10~09:30 - Panel Discussion 09:30~10:00
-
Optimal LDL-C goals for secondary prevention in high-risk patients - a cardiologist’s perspective
Hyun Sung Joh Seoul National University, Republic of Korea 13:00~13:20 -
Optimal LDL-C level for stroke prevention - insights from a neurologist’s perspective
Wookjin Yang University of Ulsan, Republic of Korea 13:20~13:40 -
Different LDL-C targets by duration of diabetes: what is the evidence? - an endocrinologist’s perspective
Young-Sang Lyu Chosun University, Republic of Korea 13:40~14:00 - Panel Discussion 14:00~14:30
-
Glutamine homeostasis: an overlooked axis in cardiometabolic inflammation
Laurent Yvan-Charvet INSERM, France 16:45~17:05 -
Myeloid metabolism in the amplification and resolution of cardiac inflammation
Edward Thorp Northwestern University, USA 17:05~17:25 -
Therapeutic promise of ANGPTL4 in cardiovascular inflammation
Yong Sook Kim Chonnam National University, Republic of Korea 17:25~17:45 - Panel Discussion 17:45~18:15
-
New approaches to treating hypertriglyceridemia in patients with renal impairment
Young-Sang Lyu Chosun University, Republic of Korea 07:50~08:02 -
Pravastatin’s effects on special populations
Jae Yoon Park Dongguk University, Republic of Korea 08:02~08:14 -
Comparative effectiveness of lercanidipine and amlodipine on MACE in hypertensive patients
Hyung Joon Joo Korea University, Republic of Korea 08:14~08:26
-
Anti-obesity effects of bioactive compound from natural products: a mechanism-oriented approach focusing on cellular signaling and metabolic regulation
Choon Young Kim Yeungnam University, Republic of Korea 08:50~09:10 -
Semaglutide for obesity treatment and cardiometabolic benefits
Yun Kyung Cho University of Ulsan, Republic of Korea 09:10~09:30 -
Tirzepatide a dual GIP GLP-1 receptor agonist in obesity and metabolic care
Sang-Ho Jo Hallym University, Republic of Korea 09:30~09:50 - Panel Discussion 09:50~10:20
-
Discrepant Effect of High-Density Lipoprotein Cholesterol on the Hematologic Malignancy Risk: A Nationwide Cohort Study
Su Youn Nam Kyungpook National University, Republic of Korea 14:50~15:05 -
Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function
Mee Kyoung Kim The Catholic University of Korea, Republic of Korea 15:05~15:20 -
Association Between Lipoprotein (a) Levels and Coronary Artery Disease (CAD) Among Patients With or Without CAD Family History
Hayato Tada Kanazawa University, Japan 15:20~15:35 -
Investigation of the Influence of Lipoprotein(a) and Oxidized Lipoprotein(a) on Plasminogen Activation and Fibrinolysis
Wen-Liang Song Brown University Health, USA 15:35~15:50 -
Fatty Acids in Childhood Obesity: A Link Between Nutrition, Metabolic Alterations and Cardiovascular Risk
Belen Davico University of Buenos Aires, Argentina 15:50~16:05 - Discussion 16:05~16:20
-
Recent update of coronary artery calcium scoring
Nor Ashikin Md Sari University of Malaya, Malaysia 16:20~16:40 -
The role of carotid ultrasonography for the primary prevention of cardiovascular disease
Jun Hwa Hong Eulji University, Republic of Korea 16:40~17:00 -
The usefulness of brachial-ankle PWV in the risk prediction for Asians
Hack-Lyoung Kim Seoul National University, Republic of Korea 17:00~17:20 - Panel Discussion 17:20~17:50
